Barclays Starts Qiagen NV (QGEN) at Overweight
Tweet Send to a Friend
Barclays analyst Luke Sergott initiates coverage on Qiagen NV (NYSE: QGEN) with a Overweight rating and a price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


